Pretreatment of lupus PMNs with 5 μg/ml of CQ reduced the rSSB-induced IL-8 production by 22.7% compared to the medium pretreatment group (Fig 4C). The gene discussed is CXCL8; the disease is systemic lupus erythematosus.